Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: A pooled analysis of 15 prospective studies

被引：26

作者：

Castillo, Jorge J.

Echenique, Ignacio A.

机构：

[1] Brown Univ, Dept Med, Warren Alpert Med Sch, Miriam Hosp, Providence, RI 02912 USA

[2] Brown Univ, Miriam Hosp, Warren Alpert Med Sch, Div Hematol & Oncol, Providence, RI USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2012年 / 87卷 / 03期

关键词：

ACTIVE ANTIRETROVIRAL THERAPY; B-CELL LYMPHOMA; PHASE-II TRIAL; AIDS-RELATED LYMPHOMA; INFUSIONAL CYCLOPHOSPHAMIDE; PREDNISONE CHEMOTHERAPY; INTENSIVE CHEMOTHERAPY; DOXORUBICIN; CHOP; VINCRISTINE;

D O I：

10.1002/ajh.22275

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：330 / 333

页数：4

共 29 条

[1]

Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy [J].

Antinori, A ;

Cingolani, A ;

Alba, L ;

Ammassari, A ;

Serraino, D ;

Ciancio, BC ;

Palmieri, F ;

De Luca, A ;

Larocca, LM ;

Ruco, L ;

Ippolito, G ;

Cauda, R .

AIDS, 2001, 15 (12) :1483-1491

[2]

Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma [J].

Boue, Francois ;

Gabarre, Jean ;

Gisselbrecht, Christian ;

Reynes, Jacques ;

Cheret, Antoine ;

Bonnet, Fabrice ;

Billaud, Eric ;

Raphael, Martine ;

Lancar, Remi ;

Costagliola, Dominique .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (25) :4123-4128

[3]

METAANALYSIS IN CLINICAL-TRIALS [J].

DERSIMONIAN, R ;

LAIRD, N .

CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188

[4]

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis [J].

Duval, S ;

Tweedie, R .

BIOMETRICS, 2000, 56 (02) :455-463

[5]

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma:: A study by the groupe d'Etude des lymphomes de l'adulte [J].

Feugier, P ;

Van Hoof, A ;

Sebban, C ;

Solal-Celigny, P ;

Bouabdallah, R ;

Fermé, C ;

Christian, B ;

Lepage, E ;

Tilly, H ;

Morschhauser, F ;

Gaulard, P ;

Salles, G ;

Bosly, A ;

Gisselbrecht, C ;

Reyes, F ;

Coiffier, B .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) :4117-4126

[6]

COMPARISON OF A STANDARD REGIMEN (CHOP) WITH 3 INTENSIVE CHEMOTHERAPY REGIMENS FOR ADVANCED NON-HODGKINS-LYMPHOMA [J].

FISHER, RI ;

GAYNOR, ER ;

DAHLBERG, S ;

OKEN, MM ;

GROGAN, TM ;

MIZE, EM ;

GLICK, JH ;

COLTMAN, CA ;

MILLER, TP .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (14) :1002-1006

[7]

Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma [J].

Habermann, Thomas M. ;

Weller, Edie A. ;

Morrison, Vicki A. ;

Gascoyne, Randy D. ;

Cassileth, Peter A. ;

Cohn, Jeffrey B. ;

Dakhil, Shaker R. ;

Woda, Bruce ;

Fisher, Richard I. ;

Peterson, Bruce A. ;

Horning, Sandra J. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) :3121-3127

[8]

Human immunodeficiency virus-associated diffuse non-Hodgkin's lymphoma in Venezuelan patients:: treatment with full-dose cyclophosphamide-doxorubicin-vincristine-prednisone without routine use of granulocyte-colony stimulating factor [J].

Hernandez, D. E. ;

Hernandez, A. E. .

EUROPEAN JOURNAL OF CANCER CARE, 2006, 15 (05) :493-496

[9]

Quantifying heterogeneity in a meta-analysis [J].

Higgins, JPT ;

Thompson, SG .

STATISTICS IN MEDICINE, 2002, 21 (11) :1539-1558

[10]

Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma [J].

Hoffmann, C ;

Wolf, E ;

Fätkenheuer, G ;

Buhk, T ;

Stoehr, A ;

Plettenberg, A ;

Stellbrink, HJ ;

Jaeger, H ;

Siebert, U ;

Horst, HA .

AIDS, 2003, 17 (10) :1521-1529

← 1 2 3 →